Monday, August 5, 2019

Dementia 2020: Call for Abstract


Submit your abstract for presenting your research at Dementia and Alzheimer’s 2020, scheduled during June 08-11, 2020.
·       Abstracts should be no longer than one A4 page in portrait layout.
·       The title of the abstract should be as concise as possible and should appear in bold, sentence cased and centered.
·       Co-authors and affiliations below the title should be in Italics (the main author's name should be underlined, and the name of the presenting author should be marked with an asterisk (*).
·       The abstract must be written in the most preferable language, i.e. English and content should have a maximum character of 300 words.
·       The main body of the abstract should be in Times New Roman, Font size 12, Justified, Line spacing 1.5.
·       References, denoted by superscript numbers in the text should be listed at the end of the text using standard Chemical Abstracts Source Service Index terminology followed by YEAR, VOLUME and PAGE.
·       The use of figures, graphs, and schemes are recommended where this aids the understanding of the text.
·       Abstracts should be submitted as in MS Word or PDF format, either via email attachment to conference email with the subject line 'conference name abstract' or online submission method via the conference website. 
·       Please include the full details of the main author and the presenting author in the email and indicate whether you are submitting an Oral or a Poster Presentation.
·       Note: There is a 1 MB limit for online abstract submission if your abstract is larger than 1 MB, then you are recommended to send it via email as an attachment.
·       After completion of the conference, speakers could submit their full-length papers to any of our related journals and it will be published within 2 months of the time period with additional charges.
·       A confirmation mail will be sent in regards to receiving your abstract, and if the submitter does not receive any mail within next 24 Hrs, he/she is suggested to the contact the respective conference coordinator, manager or ambassador.

We firmly believe that ethical conduct is the most essential virtual of any academic, hence any act of plagiarism is totally unaccepted and academic misconduct will not be tolerated.
THE CONFERENCE OFFERS TWO OPTIONS FOR ABSTRACT SUBMISSION
OPTION-1
Suited for research conducted in all the disciplines. Check a sample abstract for this option here. Abstracts submitted under the first option should contain concise statements of:
·         Backgrounds: Indicate the purpose and objective of the research, the hypothesis that was tested or a description of the problem being analyzed or evaluated.
·         Methods: Describe (the study period/ setting/location, study design, study population, data collection and methods of analysis used.
·         Results: Present as clearly and in as much detail as possible the findings/outcome of the study. Please summarize any specific results.
·         Conclusions: Explain the significance of your findings/outcomes of the study of HIV prevention, treatment, care and/or support, and Future Implications of the results.
The following review criteria will be used in scrolling abstracts submitted under OPTION 1:
·         Is there a clear background and Justified objective?
·         Is the methodology/study design appropriate for the objectives?
·         Are the results important and clearly presented?
·         Are the conclusions supported by the results?
·         Is the study original, and does it contribute to the field?

OPTION-2
Suited for research conducted in all disciplines. Check a sample abstract for this option here. Abstracts submitted under the first option should contain concise statements of:
·         Backgrounds: Summarize the purpose, scope, and objectives, of the program, project or policy.
·         Methods: Describe the programme, project or policy period/ setting/location, the structure, key population (if applicable), activities and interventions were undertaken in support of the program, project or policy.
·         Lessons Learned: Present as clearly and in as much detail as possible the methods/findings/ outcomes of the program, project or policy; include analytic approaches, evaluation of lessons learned and best practices with a succinct description of the methods used, in addition, please summarize any specific results that specifically support your conclusions of lessons learned and best practices.
·         Conclusions: Explain the significance of the methods used and findings/outcomes of the program, project or policy for HIV prevention, treatment, care and /or support, and future implications of the results.

All submitted abstracts will go through a peer-review process carried out by a peer review committee. After the successful review of your abstract, we will guide you further steps towards your presence at our event.


No comments:

Post a Comment

Brain Diseases

Global Experts Meeting on Frontiers in Alzheimer’s Disease & Dementia Rome, Italy during Oct-14-16, 2019. Session:  Brain Diseases...